GenEdit

GenEdit is a US based biotech developing innovative genetic medicines with targeted in vivo delivery. Our NanoGalaxy® platform of proprietary, polymer based hydrophilic nanoparticles (HNPs) offer selective delivery to tissues. We are leveraging our platform to develop a pipeline of wholly owned and partnered programs with a focus on autoimmune diseases and oncology.

Address

Brisbane
CA
United States
Loading